The Association of Thyroid Peroxidase Antibodies with Microvascular Invasion in Patients with Papillary Thyroid Carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400084886

Enrollment

Unknown

Registered

2024-05-27

Start date

2024-06-01

Completion date

Unknown

Last updated

2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary thyroid carcinoma.

Interventions

Observation group:None

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1)Age = 18 years; (2) PTC confirmed by core-needle biopsy or fine-needle aspiration; and (3) no history of neck irradiation.

Exclusion criteria

Exclusion criteria: (1) other types of thyroid cancer diagnosed by biopsy; (2) patients with other cancer; (3) tumor invasion of the esophagus, trachea, or recurrent laryngeal nerve was observed; and (4) thyroid dysfunction treated with drugs or radioactive iodine.

Design outcomes

Primary

Measure	Time frame
Microinvasion (MVI) of thyroid cancer tissue specimens.;Thyroid peroxidase antibody.;multifocal;	—

Secondary

Measure	Time frame
Thyroid function.;TG;tumor sise;	—

Countries

China

Contacts

Public ContactJinlong Huo

The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi).

527636479@qq.com+86 182 7553 9929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026